Characteristics | RSV-A n = 26 | RSV-B n = 56 | P value | |
---|---|---|---|---|
Demographics | Age, months | 3.5 (2, 10) | 3 (2, 10) | 0.680 |
Gender (male) | 14 (54%) | 35 (62%) | 0.457 | |
Clinical features | Underlying diseases | 8 (31%) | 17 (30%) | 0.970 |
Extrapulmonary complications* | 10 (39%) | 23 (41%) | 0.823 | |
Disease day before admission | 4 (3, 8) | 5 (3, 7) | 0.500 | |
Febrile day before admission | 1 (0, 3) | 1 (0, 3) | 0.622 | |
Highest temperature (℃) | 38 (37, 39) | 38 (37, 38.9) | 0.971 | |
Laboratory testing results | WBC (10^9/L) | 9 (6.8, 12.9) | 9 (7, 12) | 0.823 |
Neutrophils% | 32.5 (19.6, 60.2) | 34 (22, 52) | 0.762 | |
Lymphocytes% | 53 (27, 66) | 57 (38, 64) | 0.931 | |
Monocytes% | 8 (5.5, 11) | 8 (5.7, 10) | 0.598 | |
CRP (mg/L) | 1 (1, 10.9) | 1 (1, 7.2) | 0.390 | |
CD3 + cell% | 59 (58, 62) | 59 (55, 65) | 0.976 | |
CD4 + cell% | 37 (32, 37) | 37 (35, 41) | 0.167 | |
CD8 + cell% | 20 (17, 22) | 19 (16, 21) | 0.243 | |
DNT cell% | 2.9 (1.9, 3.1) | 2 (1.4, 2.9) | 0.072 | |
CK (U/L) | 84 (68, 165) | 92 (67, 121) | 0.932 | |
CK-MB (ug/L) | 3 (1.5, 6.1) | 3.8 (2.1, 4.6) | 0.580 | |
LDH (U/L) | 327 (259, 414) | 287 (256, 317) | 0.109 | |
HBDH (U/L) | 256 (216, 310) | 236 (213, 256) | 0.209 | |
Bacterial coinfection | 5 (19%) | 6 (11%) | 0.292 | |
Outcomes | Severe/moderate/mild | 13/3/10 | 21/2/33 | 0.139 |
PICU admission | 18 (69%) | 26 (46%) | 0.054 | |
PICU stay | 1 (1,2) | 0 (0,1) | 0.300 | |
Hospital stay | 8 (7,11) | 7 (6,8) | 0.044 | |
Death | 2 (7.7%) | 1 (1.8%) | 0.235 |